GLS expression profile based on
MESO : Mesothelioma
Show statistics
Hide statistics
Comparison Statistical significance
Stage1-vs-Stage2
3.111400E-01
Stage1-vs-Stage3
2.219600E-01
Stage1-vs-Stage4
9.079600E-01
Stage2-vs-Stage3
7.073000E-01
Stage2-vs-Stage4
5.121400E-01
Stage3-vs-Stage4
2.638200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
MESO : Mesothelioma
Show statistics
Hide statistics
Comparison Statistical significance
Caucasian-vs-AfricanAmerican
N/A
Caucasian-vs-Asian
N/A
AfricanAmerican-vs-Asian
N/A
Pan-cancer view
Methylation
Survival
Correlated genes
MESO : Mesothelioma
Show statistics
Hide statistics
Comparison Statistical significance
Male-vs-Female
3.992200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
MESO : Mesothelioma
Show statistics
Hide statistics
Comparison Statistical significance
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.509000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.892200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.576400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.429600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.027800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.385400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
MESO : Mesothelioma
Show statistics
Hide statistics
Comparison Statistical significance
Biphasic-VS-Diffuse_malignant
3.536000E-01
Biphasic-VS-Epithelioid
1.068800E-01
Biphasic-VS-Sarcomatoid
N/A
Diffuse_malignant-VS-Epithelioid
9.105400E-01
Diffuse_malignant-VS-Sarcomatoid
N/A
Epithelioid-VS-Sarcomatoid
N/A
Pan-cancer view
Methylation
Survival
Correlated genes
MESO : Mesothelioma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
N0-vs-N1
2.635400E-01
N0-vs-N2
5.187800E-01
N0-vs-N3
8.496200E-01
N1-vs-N2
2.048800E-01
N1-vs-N3
5.002600E-01
N2-vs-N3
9.397000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
MESO : Mesothelioma Note
Whole exome sequencing data is not available for 4 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data.
Show statistics
Hide statistics
Comparison Statistical significance
TP53-Mutant-vs-TP53-NonMutant
5.048400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
GLS expression profile based on
MESO : Mesothelioma
Show statistics
Hide statistics
Comparison Statistical significance
Stage1-vs-Stage2
3.111400E-01
Stage1-vs-Stage3
2.219600E-01
Stage1-vs-Stage4
9.079600E-01
Stage2-vs-Stage3
7.073000E-01
Stage2-vs-Stage4
5.121400E-01
Stage3-vs-Stage4
2.638200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
MESO : Mesothelioma
Show statistics
Hide statistics
Comparison Statistical significance
Caucasian-vs-AfricanAmerican
N/A
Caucasian-vs-Asian
N/A
AfricanAmerican-vs-Asian
N/A
Pan-cancer view
Methylation
Survival
Correlated genes
MESO : Mesothelioma
Show statistics
Hide statistics
Comparison Statistical significance
Male-vs-Female
3.992200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
MESO : Mesothelioma
Show statistics
Hide statistics
Comparison Statistical significance
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.509000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.892200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.576400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.429600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.027800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.385400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
MESO : Mesothelioma
Show statistics
Hide statistics
Comparison Statistical significance
Biphasic-VS-Diffuse_malignant
3.536000E-01
Biphasic-VS-Epithelioid
1.068800E-01
Biphasic-VS-Sarcomatoid
N/A
Diffuse_malignant-VS-Epithelioid
9.105400E-01
Diffuse_malignant-VS-Sarcomatoid
N/A
Epithelioid-VS-Sarcomatoid
N/A
Pan-cancer view
Methylation
Survival
Correlated genes
MESO : Mesothelioma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
N0-vs-N1
2.635400E-01
N0-vs-N2
5.187800E-01
N0-vs-N3
8.496200E-01
N1-vs-N2
2.048800E-01
N1-vs-N3
5.002600E-01
N2-vs-N3
9.397000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
MESO : Mesothelioma Note
Whole exome sequencing data is not available for 4 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data.
Show statistics
Hide statistics
Comparison Statistical significance
TP53-Mutant-vs-TP53-NonMutant
5.048400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
